Bilousova Natalia
Department of Pharmacy, Shupyk National Healthcare University of Ukraine, Kyiv, Ukraine.
J Pharm Policy Pract. 2025 Apr 8;18(1):2484577. doi: 10.1080/20523211.2025.2484577. eCollection 2025.
According to WHO's data, a significant number of deaths from CVD is observed in Ukraine. In today's conditions, the problems of ensuring the availability of medicines and pharmaceutical care for patients with CHD and comorbid conditions are being addressed at all levels of management of the Ukrainian healthcare sector in conditions of limited funds, resources and martial law. The scientific development of a conceptual model for providing pharmaceutical care to such patients, aimed at reducing the burden on the healthcare system and ensuring the safe use of medicines in compliance with European legislation, is highly relevant. The methods used in this work include information retrieval, analysis, synthesis, generalisation, induction and deduction, synergistic, dialectical, and modelling. The conceptual model of pharmaceutical care for patients with CHD and comorbid conditions was developed and substantiated. The place and role of pharmacists in the context of participation in interprofessional collaboration in multidisciplinary teams is defined. The rationale for involving pharmacists in multidisciplinary teams has been substantiated, as this will enhance the quality of personalised care, prevent potential medicines interactions considering their metabolic profiles, reduce the risk of adverse reactions and improve patient adherence to pharmacotherapy. The model of pharmaceutical care for patients with CHD and comorbid conditions takes into account the cardiovascular continuum and pharmacotherapy, which will lead to a decrease in disease progression, pharmacotherapeutic risks, reduce the burden on the healthcare system and guarantee the safety of medicines use. Implementation of the conceptual model of pharmaceutical care for patients with CHD and comorbid conditions in pharmaceutical practice requires revision of educational training programmes.
根据世界卫生组织的数据，乌克兰有大量心血管疾病死亡病例。在当前情况下，乌克兰医疗保健部门各级管理层面都在解决冠心病及合并症患者药品供应和药学服务问题，而资金、资源有限且处于战时状态。科学制定针对此类患者的药学服务概念模型，旨在减轻医疗系统负担并确保药品使用符合欧洲法规且安全，这极具现实意义。本研究采用的方法包括信息检索、分析、综合、归纳、演绎、协同、辩证和建模。已开发并论证了冠心病及合并症患者药学服务的概念模型。明确了药剂师在多学科团队跨专业协作中的地位和作用。论证了药剂师参与多学科团队的合理性，因为这将提高个性化护理质量，根据患者代谢情况预防潜在药物相互作用，降低不良反应风险并提高患者药物治疗依从性。冠心病及合并症患者药学服务模型考虑了心血管连续过程和药物治疗，这将减少疾病进展、药物治疗风险，减轻医疗系统负担并确保用药安全。在药学实践中实施冠心病及合并症患者药学服务概念模型需要修订教育培训项目。
